|
Liraglutide May Increase Bone Strength, Study Shows
|
The GLP-1 receptor agonist liraglutide used to treat patients with type 2 diabetes (T2D) for 26 weeks had no impact on bone resorption, even though subjects lost weight.
|
|
Read more
|
|
|
ADVERTISEMENT
|
|
|
Predisposition to Bone Mineral Density Determines Fracture Risk
|
A patient's genetic predisposition to low bone mineral density can increase their risk for osteoporotic fractures, according to a new genome-wide association study.
|
|
Read more
|
|
|
